Schedule 13G ownership disclosure
Verona Pharma plc
Security class unavailable · CUSIP: 0BYW2KH80
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,296,845
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-007349
- Form type
- SC 13G
- Filer
- Tekla Capital Management LLC
- CIK
- CIK 1300336
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership